Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial

BACKGROUND: The study goal was to determine whether changes in relative cerebral blood volume (rCBV) derived from dynamic susceptibility contrast (DSC) MRI are predictive of overall survival (OS) in patients with recurrent glioblastoma multiforme (GBM) when measured 2, 8, and 16 weeks after treatmen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Schmainda, Kathleen M., Zhang, Zheng, Prah, Melissa, Snyder, Bradley S., Gilbert, Mark R., Sorensen, A. Gregory, Barboriak, Daniel P., Boxerman, Jerrold L.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2015
Materias:
Neuroimaging
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4490871/
https://ncbi.nlm.nih.gov/pubmed/25646027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou364
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares